Infinity Pharmaceuticals | INFI - El Costo De Ventas





El Costo De Ventas Cambio Fecha
AbbVie USD 4.22B 329M 2026-03
Amgen USD 1.6B 187M 2026-03
AstraZeneca USD -204M 3.48B 2026-03
Bristol-Myers Squibb USD 3.86B 1.07B 2026-03
Cipla INR 26.32B 2.79B 2026-03
Clal Biotechnology ILS 16.49M 2.64M 2022-06
Compugen USD 3.54M 1.89M 2025-12
CSL USD 3.87B 2.08B 2025-12
Eisai JPY 52.02B 931M 2026-03
Eli Lilly USD 3.58B 205M 2026-03
Gilead Sciences USD 1.44B 174M 2026-03
GlaxoSmithKline GBP 1.88B 736M 2026-03
Grifols EUR 1.51B 184.45M 2025-12
Incyte USD 104.5M 16.68M 2026-03
Infinity Pharmaceuticals USD 352K 89K 2023-06
Ionis Pharmaceuticals USD 3M 5M 2026-03
J&J USD 8.07B 103M 2026-03
Novartis USD 3.46B 83M 2026-03
Pfizer USD 4.59B 1.7B 2026-03
Roche Holding CHF 8.48B 4.61B 2025-12
TG Therapeutics USD 33.51M 4.63M 2026-03